A Global Phase 3 Safety Study of 120 mcg rLP2086 Vaccine in Adolescents and Young Adults Aged 10 to 25 Years
Completed · Phase 3 · Has a placebo group
Conditions studied: Meningitis, Meningococcal
In brief
A multicenter phase 3 safety trial in which 5,700 subjects will be assigned in a 2:1 ratio to receive 120 μg rLP2086 vaccine in a 0, 2, 6 month schedule or control. The control group will receive HAVRIX vaccine at month 0 and 6 and saline at month 2. All subjects will be followed for 6 months after the last vaccination to assess safety and tolerability.
Key facts
- Study ID
- NCT01352793
- Run by
- Pfizer
- People needed
- 5715
- Starts
- 2012-11-01
- Expected to finish
- 2014-09-01
- Last updated by the study team
- 2015-03-11
Who can join
Age: 10 and older, up to 25. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Healthy subjects aged 10 to 25 years.
You may not qualify if…
- Previous vaccination with Hepatitis A virus vaccine
- Previous vaccination with investigational meningococcal B vaccine
- History of culture-proven N. meningitidis serogroup B disease
- Any neuroinflammatory or autoimmune condition
- Any immune defect that would prevent an effective response to the study vaccine
Where it is running
- Clinical Research Advantage, Inc. / East Valley Family Physicians, PLC — Chandler, Arizona, United States
- Clinical Research Advantage, Inc/ East Valley Family Physicians, PLC — Chandler, Arizona, United States
- Cassidy Medical Group/Clinical Research Advantage — Tempe, Arizona, United States
- Clinical Research Advantage, Inc. / East Valley Family Physicians, PLC — Tempe, Arizona, United States
- Clinical Research Advantage, Inc./Prairie Fields Family Medicine, PC Administrative/Mailing Address — Tempe, Arizona, United States
- Harrisburg Family Medical Center — Harrisburg, Arkansas, United States
- Accelovance. Inc — San Diego, California, United States
- Benchmark Research — San Francisco, California, United States
- Cassidy Medical Group/Clinical Research Advantage — Vista, California, United States
- Avail Clinical Research, LLC — DeLand, Florida, United States
- Jacksonville Center for Clinical Research — Jacksonville, Florida, United States
- Optimal Research, LLC — Melbourne, Florida, United States
- Accelovance — Melbourne, Florida, United States
- Miami Research Associates — South Miami, Florida, United States
- Accelovance,Inc. — Mishawaka, Indiana, United States
- Clinical Research Advantage,Inc/Ridge Family Practice — Council Bluffs, Iowa, United States
- Kentucky Pediatric/Adult Research — Bardstown, Kentucky, United States
- Clinical Research Advantage, Inc./ Pediatric Partners, LLC Additional Site-No IP — Fremont, Nebraska, United States
- Prairie Fields Family Medicine/Clinical Research Advantage — Fremont, Nebraska, United States
- Rochester Clinical Research, Inc. — Rochester, New York, United States
- Rapid Medical Research. Inc. — Cleveland, Ohio, United States
- Ohio Pediatric Research Association — Dayton, Ohio, United States
- Coastal Carolina Research Center — Mt. Pleasant, South Carolina, United States
- PMG Research of Bristol — Bristol, Tennessee, United States
- Accelovance,Inc. — Huntsville, Alabama, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.